Investigation of the effects of tamsulosin on blood pressure in normotensive, controlled hypertensive, and uncontrolled hypertensive men with benign prostatic hyperplasia

Journal of Health Science

Volumn 47, Issue 2, 2001, Pages 192-202

  Yasukawa, K ^a   Miyazawa, Y ^a   Tajima, Y ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Benign prostatic hyperplasia; Hypertension; Hypotensive effect; Tamsulosin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; ENALAPRIL; PLACEBO; TAMSULOSIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

EID: 0035060211     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.47.192     Document Type: Article

References (22)

1. Management of symptomatic BPH in the US: Who is treated and how?
2. Epidemiology and natural history of benign prostatic hyperplasia
3. New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States
4. The economics of benign prostatic hyperplasia treatment: A literature review
5. Recent developments in the surgical management of benign prostatic hyperplasia
6. Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia
7. 1-adrenoceptor antagonists in benign prostatic hyperplasia: Rationale and clinical experience
8. Benign prostatic hyperplasia: New concepts in the 1990s
9. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)
10. The use of alpha-adrenergic blockers in benign prostatic obstruction
11. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle
12. Alpha-1-adrenoceptor subtypes in the human prostate
13. 1A-Adrenergic receptors in the isolated human prostate
14. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia
15. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia
16. Lack of clinical interaction effects between tamsulosin and enalapril
17. Study of possible pharmacodynamic interactions between tamsulosin and nifedipine in subjects with essential hypertension
18. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: Pharmacodynamic effect
19. 1A-adrenergic antagonist
20. Terazosin in benign prostatic hyperplasia: Effects on blood pressure in normotensive and hypertensive men